...
首页> 外文期刊>International Journal of Nanomedicine >A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for “smart” small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells
【24h】

A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for “smart” small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells

机译:一种新型的聚酰胺酰胺-聚乙二醇-环状RGD树突状纳米载体,用于“变性”甲状腺相关癌细胞中“智能”的小干扰RNA递送和人源性基因相关的体外抗肿瘤作用

获取原文
           

摘要

Abstract: The application of RNA interference techniques is promising in gene therapeutic approaches, especially for cancers. To improve safety and efficiency of small interfering RNA (siRNA) delivery, a triblock dendritic nanocarrier, polyamidoamine-polyethylene glycol-cyclic RGD (PAMAM-PEG-cRGD), was developed and studied as an siRNA vector targeting the human ether-à-go-go-related gene (hERG) in human anaplastic thyroid carcinoma cells. Structure characterization, particle size, zeta potential, and gel retardation assay confirmed that complete triblock components were successfully synthesized with effective binding capacity of siRNA in this triblock nanocarrier. Cytotoxicity data indicated that conjugation of PEG significantly alleviated cytotoxicity when compared with unmodified PAMAM. PAMAM-PEG-cRGD exerted potent siRNA cellular internalization in which transfection efficiency measured by flow cytometry was up to 68% when the charge ratio (N/P ratio) was 3.5. Ligand-receptor affinity together with electrostatic interaction should be involved in the nano-siRNA endocytosis mechanism and we then proved that attachment of cRGD enhanced cellular uptake via RGD-integrin recognition. Gene silencing was evaluated by reverse transcription polymerase chain reaction and PAMAM-PEG-cRGD-siRNA complex downregulated the expression of hERG to 26.3% of the control value. Furthermore, gene knockdown of hERG elicited growth suppression as well as activated apoptosis by means of abolishing vascular endothelial growth factor secretion and triggering caspase-3 cascade in anaplastic thyroid carcinoma cells. Our study demonstrates that this novel triblock polymer, PAMAM-PEG-cRGD, exhibits negligible cytotoxicity, effective transfection, “smart” cancer targeting, and therefore is a promising siRNA nanocarrier.
机译:摘要:RNA干扰技术的应用在基因治疗方法中很有前景,特别是对于癌症。为了提高小干扰RNA(siRNA)递送的安全性和效率,开发了三嵌段树突状纳米载体,聚酰胺酰胺-聚乙二醇-环RGD(PAMAM-PEG-cRGD),并作为靶向人类以太的siRNA载体进行了研究。人间变性甲状腺癌细胞中的go-go相关基因(hERG)。结构表征,粒度,ζ电势和凝胶阻滞分析证实了在该三嵌段纳米载体中成功合成了具有有效siRNA结合能力的完整三嵌段组分。细胞毒性数据表明,与未修饰的PAMAM相比,PEG的缀合可显着减轻细胞毒性。 PAMAM-PEG-cRGD发挥了有效的siRNA细胞内在化作用,其中当电荷比(N / P比)为3.5时,通过流式细胞术测得的转染效率高达68%。配体受体亲和力与静电相互作用应参与纳米siRNA内吞机制,然后我们证明了cRGD的附着通过RGD-整合素识别增强了细胞摄取。通过逆转录聚合酶链反应评估基因沉默,PAMAM-PEG-cRGD-siRNA复合物将hERG的表达下调至对照值的26.3%。此外,通过消除血管内皮生长因子的分泌并触发间变性甲状腺癌细胞中的caspase-3级联反应,hERG的基因敲除引发生长抑制以及激活的细胞凋亡。我们的研究表明,这种新型三嵌段聚合物PAMAM-PEG-cRGD表现出微不足道的细胞毒性,有效的转染,“智能”靶向癌症,因此是一种有前途的siRNA纳米载体。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号